ASCP 2025 is a focused mobile guide to the 2025 ASCP Annual Meeting, designed for clinicians, researchers, regulators and industry professionals who follow advances in psychopharmacology. The app highlights the meeting’s scientific priorities — including neuropsychiatric drug development, the implications of diagnostic changes, and the rise of personalized interventions guided by biomarkers or genetic information — and summarizes the program leadership and advisory structures that shape the agenda. Users may download ASCP 2025 to keep a concise reference of committees, review leadership, and the new industry advisory initiatives that inform regulatory and development discussions.
Key Features
⭐ Concise overview of the 2025 meeting themes, including neuropsychiatric drug development and personalized interventions.
⭐ Profiles of the Program Committee and its chairs, offering context on who is shaping the agenda.
⭐ Information on the Review Subcommittee and its role in evaluating program submissions.
⭐ Coverage of the newly launched Industry Advisory Council and its leadership.
Advantages
✅ Puts meeting priorities and leadership in one easy-to-scan interface for busy professionals.
✅ Clarifies how regulatory, academic, and industry representatives converge on key development topics.
✅ Helps users understand the meeting’s emphasis on diagnostics, biomarkers, and personalized approaches.
✅ Serves as a handy reference for identifying committee contacts and organizational direction.
Disadvantages
❎ Focused specifically on the 2025 Annual Meeting, so it is not a comprehensive resource for broader ASCP activities.
❎ Content centers on program direction and leadership rather than full conference proceedings or scientific papers.
Development Team
ASCP 2025 reflects the meeting’s organizational leadership: the Program Committee is chaired by Drs. Mark Rapaport and Tiffany Farchione and includes representatives from the ASCP community, FDA, EMA, NIMH, NIDA, NIAAA and academic members; the Review Subcommittee is led by Drs. Manish Jha and Carlos Blanco; and the ASCP Industry Advisory Council is led by Drs. Ross Baker and Julie Adams.
